establish
mous
model
show
symptom
coronari
arter
consecut
inject
caw
releas
candida
albican
studi
examin
neutrophil
activ
initi
period
caw
inject
intraperiton
min
h
inject
blood
profil
neutrophil
function
determin
time
level
inflammatori
cytokin
chemokin
plasma
measur
furthermor
level
marker
lesion
arteri
endotheli
cell
measur
count
peripher
leukocyt
increas
immedi
caw
inject
especi
involv
neutrophil
vitro
sensit
neutrophil
stimuli
enhanc
moreov
proinflammatori
cytokin
increas
plasma
initi
follow
increas
gcsf
solubl
local
messag
arteri
wall
significantli
increas
h
caw
inject
decreas
level
observ
plasma
suggest
complement
activ
consumpt
summari
neutrophil
activ
occur
caw
inject
follow
complement
activ
product
proinflammatori
cytokin
chemokin
gcsf
may
involv
develop
coronari
arter
recent
clinic
relev
fungal
diseas
increas
mainli
increas
popul
immunocompromis
individu
includ
infect
hiv
transplant
recipi
patient
cancer
zupanickrmek
nemet
neutrophil
play
key
role
candida
albican
c
albican
infect
urban
et
al
fradin
et
al
c
albican
organ
expos
erythrocyt
mononuclear
cell
plasma
blood
lack
neutrophil
becom
physiolog
activ
rapidli
switch
filament
growth
contrast
presenc
neutrophil
arrest
c
albican
growth
urban
et
al
fradin
et
al
anim
model
use
clarifi
mechan
infect
process
genet
background
differ
develop
strategi
therapi
nagimiura
et
al
aratani
et
al
spellberg
et
al
microorgan
microorganismderiv
product
associ
specif
diseas
exampl
certain
campylobact
jejuni
strain
trigger
guillainbarr
syndrom
strain
trigger
fisher
syndrom
japanes
popul
takahashi
et
al
esper
et
al
report
new
coronaviru
hcovnh
infect
associ
kawasaki
diseas
esper
et
al
recent
iwai
et
al
identifi
oral
microorgan
lesion
buerger
diseas
suggest
possibl
etiolog
link
buerger
diseas
chronic
infect
oral
bacteri
infect
iwai
et
al
establish
mous
model
show
symptom
coronari
arter
follow
consecut
inject
mice
watersolubl
polysaccharid
candida
sp
caw
nagimiura
et
al
ohno
studi
examin
neutrophil
activ
subsequ
event
singl
inject
caw
fig
elisa
kit
mous
purchas
bd
bioscienc
ca
usa
medic
biolog
laboratori
nagoya
japan
solubl
r
system
mn
usa
gcsf
gmcsf
analyza
mn
us
fmetleuph
fmlp
purchas
peptid
institut
osaka
japan
tmb
cytochalasin
b
cb
cytochrom
c
rpmi
medium
aprotinin
pmsf
purchas
sigma
chemic
co
mo
usa
casein
purchas
calbiochem
co
darmstadt
germani
taqman
univers
pcr
master
mix
purchas
pe
biosystem
nj
usa
monoclon
antibodi
peroxidaseconjug
igg
fraction
mous
purchas
hycult
biotechnolog
uden
netherland
mp
biochem
inc
ca
usa
respect
male
mice
purchas
charl
river
japan
kept
spf
condit
use
accord
guidelin
anim
care
nation
institut
infecti
diseas
mice
use
experi
week
age
prepar
administr
caw
caw
prepar
c
albican
strain
accord
convent
method
nagimiura
et
al
caw
dissolv
pb
autoclav
ml
materi
mgml
intraperiton
inject
mous
vitro
assay
neutrophil
isol
caseininduc
periton
exud
cell
cocultur
caw
rpmi
medium
contain
mm
pmsf
aprotinin
coronari
arteri
segment
fix
buffer
formaldehyd
paraffinembed
section
stain
hematoxylin
eosin
peripher
blood
collect
heart
ad
leukocyt
profil
analyz
use
autom
instrument
mitsubishi
bcl
corp
tokyo
japan
peripher
blood
collect
heart
ad
lysi
min
subsequ
centrifug
cell
suspend
hbss
bone
marrow
cell
prepar
shinbon
cell
incub
mab
surfac
marker
bd
pharmingen
ca
usa
use
flow
cytometr
analysi
analyz
facscalibur
use
cellquest
softwar
bd
bioscienc
ca
usa
heparin
blood
collect
heart
neutrophil
prepar
mpo
releas
superoxid
gener
measur
describ
previous
ishidaokawara
et
al
level
proinflammatori
cytokin
solubl
gcsf
gmcsf
plasma
use
individu
elisa
prepar
periton
exud
neutrophil
measur
cytokin
product
level
cocultur
neutrophil
caw
normal
mice
intraperiton
inject
ml
casein
pb
exud
cell
contain
resid
macrophag
caseininduc
neutrophil
recov
h
lavag
ml
pb
exud
cell
put
onto
msmf
japan
immunoresearch
laboratori
co
ltd
takasaki
japan
centrifug
min
room
temperatur
neutrophil
suspend
cellsml
medium
contain
mm
pmsf
aprotinin
cocultur
mgml
caw
h
end
cultur
cultur
supernat
prepar
centrifug
level
cytokin
determin
use
elisa
kit
thorac
aorta
mice
isol
frozen
immedi
detect
mrna
total
aortic
rna
mous
isol
use
isogen
nippon
ene
tokyo
japan
one
microgram
rna
revers
transcrib
revertra
ace
toyobo
osaka
japan
obtain
cdna
realtim
pcr
perform
use
abi
prism
sequenc
detect
system
appli
biosystem
ca
us
accord
manufactur
protocol
primer
taqman
probe
specif
obtain
assayondemand
gene
express
product
appli
biosystem
endogen
control
level
gapdh
sampl
measur
use
taqman
rodent
gapdh
control
reagent
vic
appli
biosystem
data
analys
perform
abi
prism
sd
softwar
version
appli
biosystem
peripher
blood
collect
heart
ad
one
monoclon
antibodi
coat
elisa
plate
overnight
wash
block
done
fc
h
sampl
plasma
ad
plate
h
wash
peroxidas
antibodi
ad
plate
wash
ophenylenediamin
chlorid
ad
plate
min
final
reaction
stop
n
hydrogen
sulphat
measur
nm
auto
reader
nippon
bunko
tokyo
japan
western
blot
perform
use
mous
monoclon
antibodi
peroxidaselabel
antirat
igg
antibodi
fig
chang
blood
profil
caw
inject
peripher
blood
collect
heart
blood
profil
analyz
mitsubishi
kagaku
bcl
inc
total
leukocyt
number
ratio
b
neutrophil
c
lymphocyt
monocyt
respect
n
group
result
express
mean
sd
statist
analysi
use
mannwhitney
utest
probabl
valu
consid
signific
sever
coronari
arter
daili
inject
caw
mgmouseday
day
order
compar
initi
event
develop
coronari
arter
current
studi
employ
one
shot
inject
caw
dose
mgmous
four
week
caw
inject
protocol
arter
evid
coronari
aorta
fig
caw
inject
total
leukocyt
count
increas
later
return
baselin
level
h
fig
ratio
lymphocyt
decreas
caw
inject
ratio
neutrophil
promptli
increas
fig
c
ratio
monocyt
increas
fig
confirm
leukocyt
count
flow
cytometr
analysi
peripher
bone
marrow
cell
caw
inject
done
tabl
bone
marrow
cell
number
tibia
significantli
increas
h
caw
inject
data
shown
ratio
cell
bone
marrow
significantli
decreas
h
caw
inject
ratio
cell
peripher
blood
increas
suggest
neutrophil
bone
marrow
promptli
migrat
peripher
blood
caw
inject
assess
function
respons
neutrophil
caw
inject
mpo
releas
superoxid
gener
fig
fmlpinduc
mpo
releas
neutrophil
enhanc
caw
inject
fig
spontan
mpo
releas
chang
fig
addit
fmlp
pmainduc
superoxid
gener
enhanc
follow
vivo
caw
inject
fig
sinc
activ
neutrophil
observ
vivo
inject
caw
proinflammatori
cytokin
level
plasma
measur
fig
product
increas
fig
level
b
c
significantli
increas
transient
first
h
caw
inject
level
gcsf
plasma
increas
sever
hour
caw
inject
maintain
h
caw
inject
fig
f
hand
gmcsf
detect
h
caw
inject
data
shown
sinc
significantli
increas
product
cytokin
caseininduc
neutrophil
also
measur
fig
product
enhanc
exposur
neutrophil
caw
fig
nearli
presenc
absenc
caw
fig
b
sinc
marker
activ
endotheli
cell
assay
plasma
solubl
vivo
infus
caw
gradual
increas
plasma
caw
inject
fig
addit
mrna
extract
thorac
aortic
wall
also
significantli
increas
h
caw
inject
fig
activ
complement
examin
fig
plasma
decreas
time
depend
caw
inject
gradual
return
normal
thereaft
fig
confirm
western
blot
analysi
fig
result
suggest
neutrophil
activ
trigger
complement
activ
singl
inject
studi
focus
neutrophil
activ
relat
develop
coronari
arter
singl
inject
caw
dose
mgmous
induc
coronari
arter
week
featur
intens
neutrophil
accumul
coronari
arteri
wall
observ
similar
fig
cytokin
releas
plasma
caw
inject
heparin
blood
obtain
heart
caw
inject
plasma
separ
proinflammatori
cytokin
level
measur
elisa
kit
b
c
e
f
gcsf
respect
n
group
develop
coronari
arter
daili
inject
caw
mgmouseday
day
nagimiura
et
al
ohno
blood
neutrophil
subsequ
monocyt
increas
lymphocyt
count
decreas
addit
ratio
cell
bone
marrow
decreas
suggest
migrat
neutrophil
bone
marrow
peripher
blood
caw
inject
gcsf
caw
inject
fmlpinduc
mpo
releas
neutrophil
enhanc
pma
fmlpinduc
superoxid
gener
vivo
inject
result
suggest
caw
increas
number
blood
neutrophil
induc
activ
earli
caw
inject
level
significantli
increas
plasma
caw
inject
cytokin
also
releas
blood
leukocyt
live
c
albican
netea
et
al
gasparoto
et
al
type
cytokin
appear
seem
differ
depend
candida
strain
compon
virul
villar
et
al
regard
caseininduc
neutrophil
significantli
enhanc
cocultur
caw
product
virtual
unchang
presenc
caw
result
suggest
product
especi
enhanc
caw
level
gcsf
plasma
maintain
h
neutrophil
level
blood
gcsf
blood
caus
increas
activ
peripher
neutrophil
caw
inject
known
complement
activ
product
may
well
candid
chemoattract
activ
neutrophil
guo
ward
mullick
et
al
solubl
marker
activ
endotheli
cell
collin
et
al
iiyama
et
al
blood
increas
caw
inject
addit
messag
significantli
increas
thorac
aortic
wall
h
caw
inject
system
local
increas
could
involv
subsequ
endotheli
cell
lesion
develop
di
lorenzo
et
al
summari
increas
number
activ
peripher
blood
neutrophil
initi
event
caw
inject
fig
cytokin
product
neutrophil
caseininduc
neutrophil
cellsml
suspend
contain
mm
pmsf
aprotinin
cocultur
mgml
caw
h
cultur
supernat
prepar
centrifug
level
cytokin
b
c
measur
respect
treat
caw
mgml
caw
n
group
fig
solubl
plasma
mrna
aorta
caw
inject
heparin
blood
obtain
heart
caw
inject
plasma
separ
measur
elisa
kit
b
total
rna
extract
mrna
isol
cdna
prepar
mrna
realtim
pcr
perform
analyz
gapdh
use
intern
control
white
bar
show
treat
caw
black
bar
show
treat
mgmous
caw
respect
n
group
perhap
follow
macrophag
activ
adapt
immun
respons
believ
neutrophil
primari
role
host
defens
c
albican
product
arter
induc
caw
might
relat
activ
neutrophil
circul
blood
accumul
arteri
aortic
wall
express
fig
mous
complement
assess
plasma
sandwich
elisa
western
blot
mm
treat
blood
prepar
heart
caw
inject
protein
detect
sandwich
elisa
use
monoclon
peroxidaselabel
polyclon
antibodi
b
detect
monoclon
antibodi
mous
